ASTELLAS PHARMA/ADR has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, December 11th, 2019 based off prior year's report dates.
ASTELLAS PHARMA/ADR Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
ASTELLAS PHARMA/ADR (OTCMKTS:ALPMY) Earnings Estimates
Current Year EPS Consensus Estimate: $1.09 EPS
Next Year EPS Consensus Estimate: $1.16 EPS
ASTELLAS PHARMA/ADR (OTCMKTS ALPMY) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | GAAP EPS | Revenue Estimate | Actual Revenue | Conference Call | Details |
|---|
12/11/2019
(Estimated) | | | | | | | | |
| 7/30/2019 | Q1 2020 | | $0.28 | $0.28 | | $3.04 billion | N/A | |
| 4/25/2019 | Q4 2019 | | $0.15 | $0.15 | | $2.67 billion | N/A | |
| 1/30/2019 | Q3 2019 | | $0.40 | $0.40 | | $3.18 billion | N/A | |
| 10/31/2018 | Q2 2019 | | $0.23 | $0.23 | | $2.85 billion | N/A | |
| 7/27/2018 | Q1 2019 | | $0.25 | $0.25 | | $3.02 billion | N/A | |
| 4/25/2018 | 3/31/2018 | $0.15 | $0.10 | $0.10 | | $2.78 billion | N/A | |
| 1/30/2018 | Q3 2018 | | $0.27 | $0.27 | | $3.19 billion | N/A | |
| 10/31/2017 | Q2 2018 | | $0.17 | $0.17 | | $2.86 billion | N/A | |
| 7/27/2017 | 6/30/2017 | $0.24 | $0.23 | $0.23 | | $2.90 billion | N/A | |
| 4/27/2017 | Q4 2017 | | $0.17 | $0.17 | | $2.69 billion | N/A | |
| 1/30/2017 | Q3 2017 | | $0.28 | $0.28 | | $3.24 billion | N/A | |
| 10/28/2016 | Q2 2017 | | $0.22 | $0.22 | | $3.07 billion | N/A | |
| 7/28/2016 | Q1 2017 | | $0.29 | $0.29 | | $3.09 billion | N/A | |
| 5/11/2016 | Q4 2016 | | $0.12 | $0.12 | | $2.66 billion | N/A | |
| 1/29/2016 | Q3 2016 | | $0.23 | $0.23 | | $3.10 billion | N/A | |
| 10/30/2015 | Q2 2016 | | $0.22 | $0.22 | | $2.82 billion | N/A | |
| 7/31/2015 | Q1 2016 | | $0.17 | $0.17 | | $2.83 billion | N/A | |
(Earnings results data provided by Zacks Investment Research)
